基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 KLHL11抗体 KLHL11抗体
  • KLHL11抗体

KLHL11抗体 新品

Mouse Monoclonal KLHL11 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-09

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
KLHL11抗体
英文名称:
Mouse Monoclonal KLHL11 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 302 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Mouse
偶联物:
靶点:
KLHL11

验证与应用

应用及物种
WB1/500 - 1/2000 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC咨询技术 Human,Mouse,Rat
ICC1/200 - 1/1000 Human,Mouse,Rat
FCM1/200 - 1/400 Human,Mouse,Rat
Elisa1/10000 Human,Mouse,Rat
   

产品详情

AliasesFLJ10572; KLHL11
Entrez GeneID55175
clone1B9A8
WB Predicted band size80kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenPurified recombinant fragment of human KLHL11 expressed in E. Coli.  
FormulationAscitic fluid containing 0.03% sodium azide.

+ +

  •  

     

       Western blot analysis using KLHL11 mouse mAb against Hela (1) and MCF-7 (2) cell lysate.    


  •  

     

       Immunofluorescence analysis of 3T3-L1 cells using KLHL11 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.    


  •  

     

       Flow cytometric analysis of K562 cells using KLHL11 mouse mAb (green) and negative control (purple).    


           

参考文献

以下是3条虚构的KLHL11抗体相关文献示例(仅供参考,非真实发表文献):

1. **文献名称**: "KLHL11-mediated ubiquitination regulates neuronal axon guidance"

**作者**: Zhang L, et al.

**摘要**: 研究揭示了KLHL11作为E3泛素连接酶复合体组分,通过泛素化修饰调控Semaphorin受体降解,影响神经元轴突导向的分子机制,实验中使用了特异性KLHL11抗体验证其与底物的相互作用。

2. **文献名称**: "KLHL11 antibody validation in paraganglioma biomarker discovery"

**作者**: Thompson R, et al.

**摘要**: 通过免疫组化及Western blot分析,证实KLHL11抗体在副神经节瘤组织中的高特异性,发现KLHL11表达缺失与肿瘤转移相关,提示其作为潜在诊断标志物的可能性。

3. **文献名称**: "Structural basis of KLHL11-Cullin3 complex assembly"

**作者**: Watanabe K, et al.

**摘要**: 利用冷冻电镜技术和KLHL11特异性抗体,解析了KLHL11与Cullin3蛋白的复合物结构,阐明了其介导底物识别的关键结构域,为靶向泛素化通路药物设计提供依据。

4. **文献名称**: "Autoantibodies against KLHL11 in autoimmune encephalitis"

**作者**: Garcia M, et al.

**摘要**: 首次报道KLHL11抗体作为新型自身免疫性脑炎生物标志物,患者血清中KLHL11抗体与海马神经元损伤相关,研究通过ELISA和免疫荧光法验证抗体致病性。

(注:以上文献为模拟生成,实际引用时需核实真实数据库)

       

背景信息

KLHL11 (Kelch-like protein 11) is a member of the Kelch-like protein family, characterized by its N-terminal BTB/POZ domain and C-terminal Kelch repeat motifs. These structural features enable KLHL11 to act as a substrate recognition component of Cullin-RING E3 ubiquitin ligase (CRL) complexes, facilitating the targeted ubiquitination and subsequent proteasomal degradation of specific proteins. KLHL11 has garnered attention for its role in cellular processes such as protein homeostasis, cytoskeletal organization, and transcriptional regulation. Dysregulation of KLHL11 is implicated in pathological conditions, including cancers and neurological disorders.

KLHL11 antibodies are critical tools for studying its expression, localization, and function. They are widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess KLHL11 protein levels in tissues or cell lines. Notably, KLHL11 has been identified as an autoantigen in paraneoplastic neurological syndromes, particularly in association with small cell lung cancer (SCLC). Antibodies against KLHL11 in patient sera serve as diagnostic biomarkers for these rare autoimmune disorders, linking malignancy to neurological autoimmunity. Research also explores KLHL11's tumor-suppressive roles in certain cancers, where its loss may promote oncogenesis. Commercial KLHL11 antibodies are typically validated for specificity and sensitivity, though variability between clones necessitates careful experimental optimization. Ongoing studies aim to clarify its interactome and therapeutic potential.

       
KLHL11抗体;KLHL11;KLHL11 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

KLHL11抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价